Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Reiss

Showing results (121-130 of 261) with videos related to

Pageof 27
Sort By:
Environmental Research|June 29, 2015
Non-radiation risk factors for leukemia: A case-control study among chornobyl cleanup workers in UkraineN Gudzenko, M Hatch, D Bazyka, et al.
Respiratory Medicine|September 28, 2011
The efficacy and tolerability of MK-0633, a 5-lipoxygenase inhibitor, in chronic asthmaYasmine S Wasfi, César Villarán, Celine Le Bailly de Tilleghem, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 9, 2002
Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the springG Philip, K Malmstrom, F C Hampel, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 29, 2006
Linear growth in prepubertal asthmatic children treated with montelukast, beclomethasone, or placebo: a 56-week randomized double-blind studyAllan B Becker, Olga Kuznetsova, J Vermeulen, et al.
American Journal of Rhinology|January 13, 2006
Montelukast effectively treats the nighttime impact of seasonal allergic rhinitisEli O Meltzer, George Philip, Steven F Weinstein, et al.
Allergy and Asthma Proceedings|July 11, 2007
Efficacy of montelukast for treating perennial allergic rhinitisGeorge Philip, Debora Williams-Herman, Piyush Patel, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 9, 2006
Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukastDavid S Pearlman, Janet van Adelsberg, George Philip, et al.
BMJ Open Respiratory Research|January 21, 2022
CC-90001, a c-Jun N-terminal kinase (JNK) inhibitor, in patients with pulmonary fibrosis: design of a phase 2, randomised, placebo-controlled trialZoran Popmihajlov, Donna J Sutherland, Gerald S Horan, et al.
Respiratory Medicine|February 4, 2012
Airway obstruction lability helps distinguish levels of disease activity in asthmaSteven Greenberg, Nancy Liu, Amarjot Kaur, et al.
The European Respiratory Journal|September 18, 1999
Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trialE Pizzichini, J A Leff, T F Reiss, et al.
Pageof 27

Showing results (121-130 of 261) with videos related to

Sort By:
Pageof 27
Environmental Research|June 29, 2015
Non-radiation risk factors for leukemia: A case-control study among chornobyl cleanup workers in UkraineN Gudzenko, M Hatch, D Bazyka, et al.
Respiratory Medicine|September 28, 2011
The efficacy and tolerability of MK-0633, a 5-lipoxygenase inhibitor, in chronic asthmaYasmine S Wasfi, César Villarán, Celine Le Bailly de Tilleghem, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 9, 2002
Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the springG Philip, K Malmstrom, F C Hampel, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 29, 2006
Linear growth in prepubertal asthmatic children treated with montelukast, beclomethasone, or placebo: a 56-week randomized double-blind studyAllan B Becker, Olga Kuznetsova, J Vermeulen, et al.
American Journal of Rhinology|January 13, 2006
Montelukast effectively treats the nighttime impact of seasonal allergic rhinitisEli O Meltzer, George Philip, Steven F Weinstein, et al.
Allergy and Asthma Proceedings|July 11, 2007
Efficacy of montelukast for treating perennial allergic rhinitisGeorge Philip, Debora Williams-Herman, Piyush Patel, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 9, 2006
Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukastDavid S Pearlman, Janet van Adelsberg, George Philip, et al.
BMJ Open Respiratory Research|January 21, 2022
CC-90001, a c-Jun N-terminal kinase (JNK) inhibitor, in patients with pulmonary fibrosis: design of a phase 2, randomised, placebo-controlled trialZoran Popmihajlov, Donna J Sutherland, Gerald S Horan, et al.
Respiratory Medicine|February 4, 2012
Airway obstruction lability helps distinguish levels of disease activity in asthmaSteven Greenberg, Nancy Liu, Amarjot Kaur, et al.
The European Respiratory Journal|September 18, 1999
Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trialE Pizzichini, J A Leff, T F Reiss, et al.
Pageof 27